RPT-UPDATE 1-Roche, Novartis approvals in Europe signal more head-to-head competition

Retrieved on: 2021-03-30 06:33:45

Tags for this article:

Click the tags to see associated articles and topics

RPT-UPDATE 1-Roche, Novartis approvals in Europe signal more head-to-head competition. View article details on hiswai:

Excerpt

Roche's Evrysdi, already approved in the United States, gained backing from the European Commission for spinal muscular atrophy (SMA), where ...

Article found on: www.reuters.com